2,931 Shares in Iradimed Corporation (NASDAQ:IRMD) Purchased by SG Americas Securities LLC

SG Americas Securities LLC acquired a new stake in shares of Iradimed Corporation (NASDAQ:IRMD) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 2,931 shares of the medical equipment provider’s stock, valued at approximately $147,000.

Other hedge funds also recently added to or reduced their stakes in the company. Bares Capital Management Inc. increased its holdings in shares of Iradimed by 0.7% in the first quarter. Bares Capital Management Inc. now owns 279,000 shares of the medical equipment provider’s stock valued at $12,273,000 after purchasing an additional 2,000 shares during the period. Dimensional Fund Advisors LP grew its position in Iradimed by 1.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 218,924 shares of the medical equipment provider’s stock valued at $9,620,000 after buying an additional 2,079 shares during the last quarter. Hillsdale Investment Management Inc. increased its stake in Iradimed by 8.6% in the 1st quarter. Hillsdale Investment Management Inc. now owns 97,400 shares of the medical equipment provider’s stock valued at $4,285,000 after buying an additional 7,680 shares during the period. Isthmus Partners LLC raised its position in Iradimed by 1.1% during the 2nd quarter. Isthmus Partners LLC now owns 72,664 shares of the medical equipment provider’s stock worth $32,000 after buying an additional 759 shares during the last quarter. Finally, Liontrust Investment Partners LLP acquired a new stake in shares of Iradimed in the 2nd quarter worth $2,830,000. 92.34% of the stock is owned by institutional investors and hedge funds.

Iradimed Price Performance

IRMD opened at $50.39 on Friday. Iradimed Corporation has a 12 month low of $38.67 and a 12 month high of $52.45. The stock has a market capitalization of $638.44 million, a P/E ratio of 34.51 and a beta of 0.79. The business has a 50 day simple moving average of $48.36 and a 200-day simple moving average of $45.19.

Iradimed (NASDAQ:IRMD) last released its quarterly earnings data on Thursday, August 1st. The medical equipment provider reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.33 by $0.05. The firm had revenue of $17.93 million during the quarter, compared to analysts’ expectations of $17.70 million. Iradimed had a return on equity of 24.71% and a net margin of 26.83%. During the same quarter in the prior year, the business posted $0.33 earnings per share. Research analysts anticipate that Iradimed Corporation will post 1.41 EPS for the current year.

Iradimed Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Tuesday, August 20th were issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 1.19%. The ex-dividend date was Tuesday, August 20th. Iradimed’s dividend payout ratio is currently 41.10%.

Analyst Upgrades and Downgrades

Separately, Roth Mkm dropped their price target on shares of Iradimed from $65.00 to $60.00 and set a “buy” rating on the stock in a research note on Friday, August 2nd.

Iradimed Profile

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.